Klinik für Strahlentherapie und Onkologie

Prof. Dr. Nikolaos Tselis

Publikationsverzeichnis

Inhalte auf dieser Seite: Originalarbeiten (chronologisch)

Originalarbeiten (chronologisch)

  1. Todte K, Tselis N, Dadmarz M, Golden G, Ferraro T, Berrettini WH, Vogel WH. Effects of strain, behavior and age on the self-administration of ethanol, nicotine, cocaine and morphine by two rat strains. Neuropsychobiology 2001;44:150-155.
  2. Anagnostopoulos G, Baltas D, Geretschlaeger A, Martin T, Papagiannis P, Tselis N, Zamboglou N. In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir High-dose-rate Brachytherapy using CT-based planning for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2003;57:1183-91.
  3. Kolotas C, Röddiger S, Strassmann G, Martin T, Tselis N, Aebersold DM, Baltas D, Zamboglou N. Palliative interstitial HDR Brachytherapy for recurrent rectal cancer. Implantation techniques and results. Strahlenther Onkol 2003;179:458-63.
  4. Kurek R, Nunez G, Tselis N, Konrad L, Martin T, Roeddiger S, Aumüller G, Zamboglou N, Lin DW, Tunn UW, Renneberg H. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients. Clin Cancer Res 2004; 10:5808-14.
  5. Heyd R, Tselis N, Ackermann H, Röddiger SJ, Zamboglou N. Functional outcome after megavoltage irradiation for heel spurs. Strahlenther Onkol 2006;182:733-739.
  6. Tselis N, Heyd R, Vogt HG, Zamboglou N. Pilomatrix carcinoma with lymph node and pulmonary metastases. Strahlenther Onkol 2006;182:727-732.
  7. Kalogera-Fountzila A, Karanikolas D, Katodritis N, Samantas E, Sarafopoulos A, Ikonomou I, Zamboglou N, Tselis N, Dimitriadis AS, Fountzilas G; AJCC. Prognostic factors and significance of the revised 6th edition of the AJCC classification in patients with locally advanced nasopharyngeal carcinoma. Strahlenther Onkol 2006;182:458-466.
  8. Tselis N, Heyd R, Zamboglou N. Pigmented villonodular synovitis of the distal radioulnar joint. Strahlenther Onkol 2006;182:247-251.
  9. Tselis N, Kolotas C, Birn G, Röddiger S, Filipowicz I, Kontova M, Fountzilas G, Selviaridis P, Baltas D, Heyd R, Anagnostopoulos G, Zamboglou N. CT-Guided Interstitial HDR Brachytherapy for Recurrent Glioblastoma Multiforme: Long-Term Results. Strahlenther Onkol 2007;183:563-570.
  10. Kolotas C, Tselis N, Sommerlad M, Röddiger S, Schnabel T, Baltas D, Kalogera-Fountzila A, Fountzilas G, Zamboglou N. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR Brachytherapy. Strahlenther Onkol 2007;183:69-75.
  11. Heyd R, Tselis N, Ackermann H, Röddiger SJ, Zamboglou N. Radiation therapy for painful heel spurs: results of a prospective randomized study. Strahlenther Onkol 2007;183:3-9.
  12. Iliadis G, Selviaridis P, Kalogera-Fountzila A, Fragkoulidi A, Baltas D, Tselis N, Chatzisotiriou A, Misailidou D, Zamboglou N, Fountzilas G. The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models. Strahlenther Onkol 2009;185:743-50.
  13. Milickovic N, Mavroidis P, Tselis N, Nikolova I, Katsilieri Z, Kefala V, Zamboglou N, Baltas D. 4D analysis of influence of patient movement and anatomy alteration on the quality of 3D U/S-based prostate HDR brachytherapy treatment delivery. Med Phys 2011;38:4982-93.
  14. Vassiliou V, Andreopoulos D, Frangos S, Tselis N, Giannopoulou E, Lutz S. Bone metastases: assessment of therapeutic response through radiological and nuclear medicine imaging modalities. Clin Oncol (R Coll Radiol) 2011;23:632-45. Review
  15. Heyd R, Rabeneck D, Dörnenburg O, Tselis N, Zamboglou N. Gorham-Stout Syndrome of the Pelvic Girdle Treated by Radiation Therapy: A Case Report. Strahlenther Onkol 2011;187:140-143.
  16. Tselis N, Ferentinos K, Kolotas C, Schirren J, Baltas D, Antonakakis A, Ackermann H, Zamboglou N. Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies. J Thorac Oncol 2011;6:545-52.
  17. Tselis N, Ratka M, Vogt HG, Kolotas C, Baghi M, Baltas D, Fountzilas G, Georgoulias V, Ackermann H, Zamboglou N. Hypofractionated accelerated CT-guided interstitial ¹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol 2011;98:57-62.
  18. Tselis N, Chatzikonstantinou G, Kolotas C, Milickovic N, Baltas D, Chung TL, Zamboglou N. Hypofractionated accelerated computed tomography-guided interstitial high-dose-rate brachytherapy for liver malignancies. Brachytherapy 2012;11:507-14.
  19. Tselis N, Tunn UW, Chatzikonstantinou G, Milickovic N, Baltas D, Ratka M, Zamboglou N. High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients. Radiat Oncol 2013;8:115.
  20. Giantsoudi D, Baltas D, Karabis A, Mavroidis P, Zamboglou N, Tselis N, Shi C, Papanikolaou N. A gEUD-based inverse planning technique for HDR prostate brachytherapy: feasibility study. Med Phys 2013;40:041704.
  21. Tselis N, Chatzikonstantinou G, Kolotas C, Milickovic N, Baltas D, Zamboglou N. Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study. Eur Radiol 2013;23:2264-70.
  22. Archavlis E, Tselis N, Birn G, Ulrich P, Baltas D, Zamboglou N. Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme. BMJ Open 2013;3:e002262.
  23. Zamboglou N, Tselis N, Baltas D, Buhleier T, Martin T, Milickovic N, Papaioannou S, Ackermann H, Tunn UW. High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results. Int J Radiat Oncol Biol Phys 2013;85:672-8.
  24. Archavlis E, Tselis N, Birn G, Ulrich P, Zamboglou N. Combined salvage therapies for recurrent glioblastoma multiforme: evaluation of an interdisciplinary treatment algorithm. J Neurooncol. 2014;119:387-95.
  25. Archavlis E, Tselis N, Birn G, Ulrich P, Zamboglou N. Salvage therapy for recurrent glioblastoma multiforme: a multimodal approach combining fluorescence-guided resurgery, interstitial irradiation, and chemotherapy. Neurol Res 2014;36:1047-55.
  26. Mavroidis P, Milickovic N, Cruz W, Tselis N, Karabis A, Stathakis S, Papanikolaou N, Zamboglou N, Baltas D. Comparison of different fractionation schedules toward a single fraction in HDR brachytherapy as monotherapy for low-risk prostate cancer using 3D radiobiological models. Int J Radiat Oncol Biol Phys 2014;88:216-23.
  27. Milickovic N, Tselis N, Karagiannis E, Ferentinos K, Zamboglou N. Iridium-Knife: Another knife in radiation oncology. Brachytherapy 2017;16:884-892.
  28. Tselis N, Hoskin P, Baltas D, Strnad V, Zamboglou N, Rödel C, Chatzikonstantinou G. High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Review of the Current Status. Clin Oncol (R Coll Radiol) 2017;29:401-411.
  29. Strouthos I, Chatzikonstantinou G, Tselis N, Bon D, Karagiannis E, Zoga E, Ferentinos K, Maximenko J, Nikolettou-Fischer V, Zamboglou N. Photobiomodulation therapy for the management of radiation-induced dermatitis: A single-institution experience of adjuvant radiotherapy in breast cancer patients after breast conserving surgery. Strahlenther Onkol 2017; 193:491-498.
  30. Tselis N, Karagiannis E, Kolotas C, Baghi M, Milickovic N, Zamboglou N. Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation. Head Neck 2017;39: 61-68.
  31. Murakami N, Ueno T, Yatsuoka W, Okamoto H, Tselis N, Masui K, Yoshida K, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, Itami J. Dose coverage comparison between "interstitial catheter-only" and "hybrid intracavitary-interstitial brachytherapy" for early stage squamous cell carcinoma of the buccal mucosa. J Contemp Brachytherapy 2018;10:486-491.
  32. Chatzikonstantinou G, Zamboglou N, Archavlis E, Strouthos I, Zoga E, Milickovic N, Hilaris B, Baltas D, Rödel C, Tselis N. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience. Strahlenther Onkol 2018;194:1171-1179.
  33. Karagiannis E, Leczynski A, Tselis N, Psanis E, Steckenreiter O, Milickovic N, Bon D, Strouthos I, Ferentinos K, Hass P, Gademann G, Baltas D, Zamboglou N. Inverse planning and inverse implanting for breast interstitial brachytherapy. Introducing a new anatomy specific breast interstitial template (ASBIT). Radiother Oncol 2018;128:421-427.
  34. Strouthos I, Chatzikonstantinou G, Zamboglou N, Milickovic N, Papaioannou S, Bon D, Zamboglou C, Rödel C, Baltas D, Tselis N. Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer. Radiother Oncol 2018;128:301-307.
  35. Umezawa R, Murakami N, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Takahashi K, Inaba K, Ito Y, Igaki H, Masui K, Yoshida K, Jingu K, Tselis N, Itami J. Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study. Brachytherapy 2018;17:368-376.
  36. Strouthos I, Tselis N, Chatzikonstantinou G, Butt S, Baltas D, Bon D, Milickovic N, Zamboglou N. High dose rate brachytherapy as monotherapy for localised prostate cancer. Radiother Oncol 2018;126:270-277.
  37. Murakami N, Shima S, Okuma K, Iijima K, Tselis N, Uematsu M, Takagawa Y, Kashihara T, Masui K, Yoshida K, Takahashi K, Inaba K, Igaki H, Nakayama Y, Itami J. Artificial ascites for organs at risk sparing in intrapelvic brachytherapy: a case report of recurrent uterine cervical carcinoma adjacent to the bowel. BJR Case Rep 2018;5:20180067.
  38. Yoshida K, Kotsuma T, Akiyama H, Yamazaki H, Takenaka T, Masui K, Tsujimoto Y, Murakami N, Uesugi Y, Shimbo T, Yoshikawa N, Yoshioka H, Nakata M, Arika T, Takaoka Y, Tanaka E, Tselis N. A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancer. J Contemp Brachytherapy 2019;11:573-578.
  39. Chatzikonstantinou G, Zamboglou N, Baltas D, Ferentinos K, Bon D, Tselis N. Image-guided interstitial high-dose-rate brachytherapy for dose escalation in the radiotherapy treatment of locally advanced lung cancer: A single-institute experience. Brachytherapy 2019;18:829-834.
  40. Fleischmann M, Martin D, Peña-Llopis S, Oppermann J, von der Grün J, Diefenhardt M, Chatzikonstantinou G, Fokas E, Rödel C, Strebhardt K, Becker S, Rödel F, Tselis N. Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy. Front Oncol 2019;9:742.
  41. Chatzikonstantinou G, Ulrich P, Archavlis E, Zamboglou N, Strouthos I, Zoga E, Baltas D, Tselis N. Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme. J Contemp Brachytherapy 2019;11:215-220.
  42. Kashihara T, Murakami N, Tselis N, Kobayashi K, Tsuchida K, Shima S, Masui K, Yoshida K, Takahashi K, Inaba K, Umezawa R, Igaki H, Ito Y, Kato T, Uno T, Itami J. Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience. J Radiat Res 2019;60:501-508.
  43. Murakami N, Shima S, Kashihara T, Tselis N, Kato T, Takagawa Y, Masui K, Yoshida K, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, Itami J. Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction. J Contemp Brachytherapy 2019;11:1-7.
  44. Strouthos I, Tselis N, Ferentinos K, Karagiannis E, Milickovic N, Chatzikonstantinou G, Feder O, Zamboglou N. Intraluminal High-Dose-Rate Brachytherapy-An Alternative Organ-Preserving Approach for Primary Male Urothelial Carcinoma With Panurethral Involvement. Pract Radiat Oncol 2020;10:e53-e56.
  45. Behmueller M, Tselis N, Zamboglou N, Zoga E, Baltas D, Rödel C, Chatzikonstantinou G. High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up. Front Oncol 2021;11:770959.
  46. Fleischmann M, Chatzikonstantinou G, Fokas E, Wichmann J, Christiansen H, Strebhardt K, Rödel C, Tselis N, Rödel F. Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer. Cancers 2021;13:5748.
  47. Mader N, Groener D, Tselis N, Banek S, Nagarajah J, Grünwald F, Sabet A. Outcome of 177Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer. Cancers 2021;13: 4193.
  48. Groener D, Baumgarten J, Haefele S, Happel C, Klimek K, Mader N, Nguyen Ngoc C, Tselis N, Chun FKH, Grünwald F, Sabet A. Salvage Radioligand Therapy with Repeated Cycles of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement. Cancers 2021;13:4017.
  49. Groener D, Nguyen CT, Baumgarten J, Bockisch B, Davis K, Happel C, Mader N, Nguyen Ngoc C, Wichert J, Banek S, Mandel P, Chun FKH, Tselis N, Grünwald F, Sabet A. Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer. EJNMMI Res 2021;11:61.
  50. Scherf C, Licher J, Mletzko C, Trommel M, Tselis N, Chatzikonstantinou G, Diefenhardt M, Rödel C, Köhn J, Ramm U. Individualized mould-based high-dose-rate brachytherapy for perinasal skin tumors: technique evaluation from a dosimetric point of view. J Contemp Brachytherapy 2021;13: 179-187.
  51. Diefenhardt M, Chatzikonstantinou G, Meissner M, Köhn J, Scherf C, Trommel M, Licher J, Ramm U, Rödel C, Tselis N. HDR brachytherapy with individual epithetic molds for facial skin cancer: techniques and first clinical experience. Int J Dermatol 2021;60:717-723.
  52. Chatzikonstantinou G, Strouthos I, Scherf C, Köhn J, Solbach C, Rödel C, Tselis N. Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer. J Radiat Res 2021;62:465-472.
  53. Nakata M, Yoshida K, Shimbo T, Yoshikawa N, Yoshioka H, Hori A, Sato C, Uesugi Y, Kogata Y, Masui K, Murakami N, Kashihara T, Akiyama H, Tselis N, Ohmichi M, Nihei K. High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report. J Contemp Brachytherapy 2021;12: 606-611.
  54. Chatzikonstantinou G, Scherf C, Köhn J, Ackermann H, Ramm U, Tselis N. Matched-pair dosimetric comparison of cardiac radiation exposure between deep-inspiration breath-hold whole-breast radiation therapy with Active Breathing Coordinator and interstitial multicatheter high-dose-rate brachytherapy as accelerated partial breast irradiation in adjuvant treatment of left-sided breast cancer after breast-conserving surgery. Strahlenther Onkol 2021;197: 308-316.
  55. Chatzikonstantinou G, Keller C, Scherf C, Bathen B, Köhn J, Tselis N. Real-world dosimetric comparison between CyberKnife SBRT and HDR brachytherapy for the treatment of prostate cancer. Brachytherapy 2021;20:44-49.
  56. Chatzikonstantinou G, Wolff R, Tselis N. Fractionated stereotactic radiotherapy as a primary or salvage treatment for large brainstem metastasis. J Cancer Res Ther 2022;18:1604-1609.
  57. Zoga E, Wolff R, Ackermann H, Meissner M, Rödel C, Tselis N, Chatzikonstantinou G. Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies. Cancers 2022;14:2391.
  58. Fleischmann M, Diefenhardt M, Trommel M, Scherf C, Ramm U, Chatzikonstantinou G, Fokas E, Rödel C, Tselis N. Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach. Strahlenther Onkol 2022;198:654-662.
  59. Akiyama H, Yoshida K, Takenaka T, Kotsuma T, Masui K, Monzen H, Sumida I, Tsujimoto Y, Miyao M, Okumura H, Shimbo T, Takegawa H, Murakami N, Inaba K, Kashihara T, Takácsi-Nagy Z, Tselis N, Yamazaki H, Tanaka E, Nihei K, Ariji Y. Effect of a lead block on alveolar bone protection in image-guided high-dose-rate interstitial brachytherapy for tongue cancer: using model-based dose calculation algorithms to correct for inhomogeneity. J Contemp Brachytherapy 2022;14:87-95.
  60. Scherf C, Ramm U, Stein T, Trommel M, Tselis N, Chatzikonstantinou G, Diefenhardt M, Rödel C, Köhn J, Licher J. Effects of iodinated contrast agent on HU-based dose calculation and dose delivered in iridium-192 high-dose-rate brachytherapy. J Contemp Brachytherapy 2022;14:80-86.
  61. Glatzer M, Tanderup K, Rovirosa A, Fokdal L, Ordeanu C, Tagliaferri L, Chargari C, Strnad V, Dimopoulos JA, Šegedin B, Cooper R, Nakken ES, Petric P, van der Steen-Banasik E, Lössl K, Jürgenliemk-Schulz IM, Niehoff P, Hermansson RS, Nout RA, Putora PM, Plasswilm L, Tselis N. Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists. Cancers 2022;14:906.
  62. Baumgarten J, Groener D, Nguyen Ngoc C, Mader N, Chaurasia M, Davis K, Wichert J, Chun FKH, Tselis N, Happel C, Grünwald F, Sabet A.  Safety and Efficacy of 177Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing 223Radium-Dichloride. Cancers 2022;14:557.
  63. Chatzikonstantinou G, Diefenhardt M, Fleischmann M, Meissner M, Scherf C, Trommel M, Ramm U, Rödel C, Tselis N, Licher J. 3D-gedruckte Moulagen für die individualisierte HDR-Brachytherapie kutaner Malignome im Gesichtsbereich: Erste klinische Erfahrungen. J Dtsch Dermatol Ges 2023;2:35-43.
  64. Mader N, Nguyen Ngoc C, Kirkgöze B, Baumgarten J, Groener D, Klimek K, Happel C, Tselis N, Chun FKH, Grünwald F, Sabet A. Extended therapy with [177Lu] Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging 2023;50:1811-1821.
  65. Groener D, Schneider S, Baumgarten J, Happel C, Klimek K, Mader N, Nguyen Ngoc C, Wichert J, Mandel P, Tselis N, Grünwald F, Sabet A. Baseline [68Ga] Ga-PSMA-11 PET/CT before [177Lu] Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions. Cancers 2023;15:473.
  66. Chatzikonstantinou G, Diefenhardt M, Fleischmann M, Meissner M, Scherf C, Trommel M, Ramm U, Rödel C, Tselis N, Licher J. Customized 3D-printed molds for high dose-rate brachytherapy in facial skin cancer: First clinical experience. J Dtsch Dermatol Ges 2023;21:35-41.
  67. Rembielak A, Mansy G, Barnes EA, Licher J, Tselis N. Advances in Skin Brachytherapy: Cosmesis and Function Preservation. Clin Oncol (R Coll Radiol) 2023;35:507-515.
  68. Yoshida K, Kotsuma T, Takaoka Y, Tamenaga S, Yamazaki H, Nose T, Murakami N, Inaba K, Akiyama H, Masui K, Takenaka T, Kubota H, Tselis N, Masuda N, Yasojima H, Takeda M, Mano M, Nakamura S, Utsunomiya K, Tanigawa N, Tanaka E. HDR-brachytherapy for accelerated partial breast irradiation: Long-term experience from a Japanese institution. J Contemp Brachytherapy 2023;15:1-8.
  69. Wenzel M, Garcia CC, Hoeh B, Jorias C, Humke C, Koll F, Tselis N, Rödel C, Graefen M, Tilki D, Chun FKH, Mandel P. Real-world evidence of outcomes of oligometastatic hormone-sensitive prostate cancer patients treated with metastasis-directed therapy. Prostate 2023 epub ahead of print.

Übersichtsarbeiten/Reviews

  1. Sinis N, Kraus A, Tselis N, Haerle M, Werdin F, Schaller HE. Functional recovery after implantation of artificial nerve grafts in the rat- a systematic review. J Brachial Plex Peripher Nerve Inj 2009;4:19.
  2. Vassiliou V, Tselis N, Kardamakis D. Osteonecrosis of the Jaws: Clinicopathologic and Radiologic Characteristics, Preventive and Therapeutic Strategies. Strahlenther Onkol 2010;186:367-73.
  3. Tselis N, Ratka M, Vogt HG, Kolotas C, Baghi M, Baltas D, Fountzilas G, Georgoulias V, Ackermann H, Zamboglou N. Hypofractionated accelerated CT-guided interstitial ¹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol 2011;98:57-62.
  4. Vassiliou V, Andreopoulos D, Frangos S, Tselis N, Giannopoulou E, Lutz S. Bone metastases: assessment of therapeutic response through radiological and nuclear medicine imaging modalities. Clin Oncol (R Coll Radiol) 2011;23:632-45.
  5. Tselis N, Maurer U, Popp W, Sack H, Zamboglou N.  Evaluation of Time, Attendance of Medical Staff, and Resources during Interstitial Brachytherapy for Prostate Cancer: DEGRO-QUIRO Trial. Accepted for publication in Strahlenther Onkol 2014;190:358-63.
  6. Strouthos I, Tselis N, Zamboglou N. Docetaxel-induced radiation recall dermatitis: A case report and literature review. Strahlenther Onkol 2016;192:730-36.
  7. Tselis N, Hoskin P, Baltas D, Strnad V, Zamboglou N, Rödel C, Chatzikonstantinou G. High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Review of the Current Status. Clin Oncol (R Coll Radiol) 2017;29:401-411.
  8. Chatzikonstantinou G, Zamboglou N, Rödel C, Zoga E, Strouthos I, Butt SA, Tselis N. High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy: A systematic review. Strahlenther Onkol 2017;193:683-691.
  9. Tselis N, Prott FJ, Ott O, Weiss C, Rödel C. Radiochemotherapy for invasive bladder cancer: An update. Urologe A 2018;57:679-685.
  10. Murakami N, Kobayashi K, Shima S, Tsuchida K, Kashihara T, Tselis N, Umezawa R, Takahashi K, Inaba K, Ito Y, Igaki H, Nakayama Y, Masui K, Yoshida K, Kato T, Itami J. A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience. BMC Cancer 2019;19:221.
  11. Tselis N, Chatzikonstantinou G. Treating the Chameleon: Radiotherapy in the management of Renal Cell Cancer. Clin Transl Radiat Oncol 2019;16:7-14.
  12. Fleischmann M, Glatzer M, Rödel C, Tselis N. Radioimmunotherapy: future prospects from the perspective of brachytherapy. J Contemp Brachytherapy 2021;13:458-467.
  13. Fleischmann M, Chatzikonstantinou G, Fokas E, Wichmann J, Christiansen H, Strebhardt K, Rödel C, Tselis N, Rödel F. Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer. Cancers 2021;13:5748.
  14. Fokas E, Glynne-Jones R, Fleischmann M, Piso P, Tselis N, Ghadimi M, Hofheinz RD, Rödel C. Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives. Cancer Treat Rev 2023;112:102490.
  15. Spohn SKB, Draulans C, Kishan AU, Spratt D, Ross A, Maurer T, Tilki D, Berlin A, Blanchard P, Collins S, Bronsert P, Chen R, Pra AD, de Meerleer G, Eade T, Haustermans K, Hölscher T, Höcht S, Ghadjar P, Davicioni E, Heck M, Kerkmeijer LGW, Kirste S, Tselis N, Tran PT, Pinkawa M, Pommier P, Deltas C, Schmidt-Hegemann NS, Wiegel T, Zilli T, Tree AC, Qiu X, Murthy V, Epstein JI, Graztke C, Gao X, Grosu AL, Kamran SC, Zamboglou C.  Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus. Int J Radiat Oncol Biol Phys 2022:S0360-3016(22)03691-4.

Buchbeiträge

  1. Zamboglou N, Tselis N, Kolotas C, Baltas D. Brachytherapy: Medical Physics, Radioisotopes and Methods. In: Fountzilas G, Barbounis V (editors). Basic Principles of Cancer Therapy. 2nd ed. Thessaloniki: University Studio Press, 2006
  2. Zamboglou N, Baltas D, Kolotas C, Tselis N. Brachytherapie: Bildverarbeitung und Bestrahlungsplanung.  In: Bamberg M, Molls M, Sack H (editors). Radioonkologie: Grundlagen. München, Wien, New York: Zuckschwerdt Verlag, 2009
  3. Zamboglou N, Tselis N, Kurek R. Multimodale Konzepte - Radiotherapie. In: Kreienberg R, Schindelmann S, Schmalfeldt B, du Bois A, Pfisterer J (editors). Management des Ovarialkarzinoms. Berlin: Springer, 2009
  4. Tselis N, Zamboglou N. High-Dose-Rate Brachytherapy in the treatment of clinically localized prostate cancer. In: Geinitz H, Roach M, van As N (editors). Radiotherapy in Prostate Cancer: Innovative Techniques and Current Controversies. Berlin: Springer, 2014.
  5. Molls M, Sackerer I, Tselis N, Duma MN, Adam M. Modern Aspects and Techniques in Radiation Treatment of Prostate Cancer. In: M Samija (editor). TUMORI PROSTATE. Hrvatska akademija znanosti i umjetnosti i Zaklada onkologij, Zaklada onkologija, 2015
  6. Stewart A, Tselis N. Gastrointestinal Brachytherapy. In: Devlin P, Stewart A (editors). Brachytherapy: Applications and Techniques, Demos Medical, Springer Publishing Company, 2015
  7. Tselis N, Mohnike K, Ricke J. Image-guided High-Dose-Rate Brachytherapy in the Treatment of Liver Cancer. In: Montemaggi P, Trombetta M, Brady LW (editors). Brachytherapy: An International Perspective Textbook. Springer International Publishing, 2016
  8. Tselis N, Baltas D, Zamboglou N. High-Dose-Rate Brachytherapy in the Treatment of clinically organ-confined Prostate Cancer. In: Montemaggi P, Trombetta M, Brady LW (editors). Brachytherapy: An International Perspective Textbook. Springer International Publishing, 2016
  9. Tselis N, Mohnike K, Ricke J. Image-guided High-Dose-Rate Brachytherapy in the Treatment of Liver Cancer. In: Montemaggi P, Trombetta M, Brady LW (editors). Brachytherapy: An International Perspective Textbook. Springer International Publishing, 2016
  10. Rödel C, Tselis N. Radiation Therapy in Bladder Cancer. In: Wenz F. (eds) Radiation Oncology. Springer, 2018
  11. Chatzikonstantinou G, Tselis N.  Radiation Therapy in Carcinomas of the Renal Pelvis and the Ureters. In: Wenz F. (eds) Radiation Oncology. Springer, 2018
  12. Tselis N, Chatzikonstantinou G. Radiation Therapy in Renal Cell Carcinoma. In: Wenz F. (eds) Radiation Oncology. Springer, 2018
MENÜ